INDEMNIFICATION AGREEMENTIndemnification Agreement • November 2nd, 2016 • Leap Therapeutics, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledNovember 2nd, 2016 Company Industry JurisdictionTHIS INDEMNIFICATION AGREEMENT (the “Agreement”) is made and entered into as of [•] between Leap Therapeutics, Inc., a Delaware corporation (the “Company”), and the person whose name appears on the signature page hereto (“Indemnitee”).
MACROCURE SHAREHOLDER VOTING AGREEMENTShareholder Voting Agreement • November 2nd, 2016 • Leap Therapeutics, Inc. • Pharmaceutical preparations
Contract Type FiledNovember 2nd, 2016 Company IndustryTHIS VOTING AGREEMENT (“Agreement”), dated as of August 29, 2016, is made by and among Leap Therapeutics, Inc., a Delaware corporation (“Leap”), and the undersigned holder (“Shareholder”) of ordinary shares (the “Shares”) and/or options, warrants or other securities of Macrocure, Ltd., a company formed under the laws of the State of Israel and registered under No. 51408376-5 with the Israeli Registrar of Companies (“M-CO”).
LEAP SHAREHOLDER VOTING AGREEMENTShareholder Voting Agreement • November 2nd, 2016 • Leap Therapeutics, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledNovember 2nd, 2016 Company Industry JurisdictionTHIS VOTING AGREEMENT (“Agreement”), dated as of August 29, 2016, is made by and among Macrocure Ltd., a company formed under the laws of the State of Israel and registered under No. 51-408376-5 with the Israeli Registrar of Companies (“M-CO”), and the undersigned holder (“Shareholder”) of shares of capital stock (the “Shares”) of Leap Therapeutics, Inc., a Delaware corporation (“Leap”).
LICENSE AGREEMENT BETWEEN ELI LILLY AND COMPANY AND DEKKUN CORPORATION EFFECTIVE AS OF JANUARY 3, 2011License Agreement • November 2nd, 2016 • Leap Therapeutics, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledNovember 2nd, 2016 Company Industry JurisdictionAs of the Effective Date, Lilly is conducting certain ongoing development activities with respect to Compound. Lilly will use Diligence to complete such activities in accordance with the following:
LICENCE AGREEMENT between LONZA SALES AG and HEALTHCARE PHARMACEUTICALS, INC.Licence Agreement • November 2nd, 2016 • Leap Therapeutics, Inc. • Pharmaceutical preparations
Contract Type FiledNovember 2nd, 2016 Company IndustryLONZA SALES AG incorporated and registered in Switzerland whose registered office is at Muenchensteinerstrasse 38, CH-4002, Basel, Switzerland (hereinafter referred to as “Lonza”), and